Received Nov 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | — | OT |
Vaccine associated acute pericarditis; This is a spontaneous report received from a Consumer or other non HCP. A 61-year-old male patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 12Apr2025 at 09:00 as dose number unknown, 0.5 ml single (Batch/Lot number: unknown) at the age of 61 years intramuscular for immunisation. The patient's relevant medical history included: "Known allergies: Sulfa drugs" (unspecified if ongoing); "Type2 diabetic" (unspecified if ongoing); "high BP" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PERICARDITIS (medically significant, life threatening) with onset 12Apr2025 at 17:00, outcome "recovering", described as "Vaccine associated acute pericarditis". The patient underwent the following laboratory tests and procedures: Blood cholesterol: high; Blood pressure measurement: high. Therapeutic measures were taken as a result of pericarditis. Clinical course: No other vaccine was administered on same date or in four weeks. It was unknown if other medications were administered in two weeks. The event was reported as Vaccine associated acute pericarditis and it resulted in Life threatening illness (immediate risk of death from the event). Patient received treatment for pericarditis for 6 months. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Blood pressure high; High cholesterol; Sulfonamide allergy; Type 2 diabetes mellitus
Test Name: cholesterol; Result Unstructured Data: Test Result:high; Test Name: BP; Result Unstructured Data: Test Result:high